Public Data
26 samples
Transcriptome profile of LX-2 cells
Accession: SRP326313
Published: 2022
cell line
bioactive entity, gene, ...
liver
Public Data
18 samples
Age-associated decline of MondoA drives cellular senescence through impaired autophagy and mitochondrial homeostasis
Accession: SRP325834
Published: 2022
cell line
bioactive entity, gene, ...
eye
Public Data
1,630 samples
Pathogen-specific innate immune response patterns are distinctly affected by genetic diversity
Accession: SRP323719
Published: 2022 in J Fungi (Basel)
primary cells
infection
blood
Public Data
12 samples
Regulated IRE1a-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer
Accession: SRP323362
Published: 2022 in Nat Commun
cell line
bioactive entity
breast
triple-negative breast carcinoma
Public Data
71 samples
Molecular profiling reveals human biomarker signatures in patients after allogeneic stem cell transplantation suffering from invasive aspergillosis
Accession: SRP320846
Published: 2022 in J Fungi (Basel)
primary cells, primary tissue
infection, other
blood
invasive aspergillosis
Public Data
15 samples
Global and p53-dependent transcriptional response of fibroblasts to Klebsiella pneumoniae
Accession: SRP320074
Published: 2022 in Oncogene
cell line
bioactive entity, gene, ...
skin of prepuce of penis, zone of skin
Public Data
63 samples
Chromatin state changes induced by targeted degradation of MLL-AF9 are phenocopied by combined DOT1L and MENIN inhibition. [RNA-Seq]
Accession: SRP316987
Published: 2022
cell line
bioactive entity
blood
acute myeloid leukemia, leukemia
Public Data
15 samples
Chromatin state changes induced by targeted degradation of MLL-AF9 are phenocopied by combined DOT1L and MENIN inhibition. [SLAM-Seq]
Accession: SRP317952
Published: 2022
cell line
bioactive entity
Public Data
50 samples
Action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells
Accession: SRP316051
Published: 2022 in NAR Cancer
cell line
bioactive entity
kidney, liver, ...
rhabdoid tumor
Public Data
20 samples
Combination treatment with BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma
Accession: SRP315400
Published: 2022 in Neuro Oncol
cell line
bioactive entity, gene, ...
brain
medulloblastoma
Public Data
4 samples
Evaluation the targeted nanobubbles mediated LND against hepatocellular carcinoma by sonodynamic therapy with RNA-Seq
Accession: SRP314366
Published: 2022 in Front Mol Biosci
cell line
bioactive entity, other
liver
hepatocellular carcinoma
Public Data
6 samples
Genome-wide epigenome mapping in human induced pluripotent cells in WT and KDM6AKO cells. [RNA-Seq]
Accession: SRP309312
Published: 2022
cell line
gene, gene: crispr
pluripotent stem cell
Public Data
8 samples
Genome-wide maps in MDA-MB-231 cells treated with or without CPUL119(4.5 µM), CPUL129(1.8 µM), CPUL149(0.9 µM)
Accession: SRP309151
Published: 2022
cell line
bioactive entity
breast
breast cancer
Public Data
40 samples
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes
Accession: SRP308489
Published: 2022 in Blood Cancer Discov
cell line, primary cells
gene, gene: crispr
blood, bone marrow, ...
acute myeloid leukemia, blast phase chronic myelogenous leukemia, ...
Public Data
68 samples
Small intestinal mucosal transcriptomics in IBS
Accession: SRP306716
Published: 2022 in Aliment Pharmacol Ther
primary tissue
duodenum, jejunum
irritable bowel syndrome